MOUNTAIN VIEW, Calif. – October 6, 2015 – Complete Genomics, Inc., a leader in whole human genome sequencing, announced today that leading UK charity Epilepsy Society has become the third customer of the company’s newly introduced Revolocity system, a supersequencer for large-scale, high-quality whole genome and whole exome sequencing.

“Genome sequencing

Complete Genomics Workshop at ASHG 2015 to Feature Game-Changing Sequencing Innovations and Their Role in Clinical Research
MOUNTAIN VIEW, Calif. – September 21, 2015 – Complete Genomics, Inc., a leader in human genomic sequencing, will host a luncheon workshop, Advances in Genome Sequencing, for attendees at the upcoming 65th Annual Meeting

Complete Genomics Previews Revolocity™ Sequencing System at European Human Genetics Conference 2015
Mater Health Services (Australia) and Radboud University Medical Center (The Netherlands) select first “supersequencer”
MOUNTAIN VIEW, Calif. – June 6, 2015 – Complete Genomics, Inc., a leader in whole human genome sequencing, today announced that Mater Health Services, a leading

Complete Genomics Satellite Meetings at European Human Genetics Conference (ESHG) 2015 to Focus on the First Integrated Genome Sequencing Solution and WGS Clinical Applications
MOUNTAIN VIEW, Calif. – May 19, 2015 – Complete Genomics, Inc., a leader in whole human genome sequencing, will host two satellite meetings at the upcoming European

Complete Genomics Workshop at ASHG 2014
Thought Leaders Address Challenges, Breakthroughs, and Innovations in Clinical Whole Genome Sequencing
MOUNTAIN VIEW, Calif. – October 15, 2014 – Complete Genomics, Inc., a leader in accurate whole human genomic sequencing, will host a luncheon workshop, Clinical Applications of Whole Genome Sequencing, for attendees at the

Complete Genomics Whole Genome Sequencing Enables Discovery of Point Mutation Responsible for Prader-Willi Syndrome
Data published in Nature Genetics demonstrate why it is important to be able to distinguish between maternal and paternal genes
MOUNTAIN VIEW, Calif. – Sept. 30, 2013 – Complete Genomics, Inc. (formerly NASDAQ: GNOM) (“Complete”), a wholly-owned subsidiary

Complete Genomics Appoints Ethan Knowlden as Senior Vice President, General Counsel, and Secretary
Knowlden brings extensive global healthcare, legal, and business development experience to his new role
MOUNTAIN VIEW, Calif. – Sept. 17, 2013 – Complete Genomics, Inc. (formerly NASDAQ: GNOM) (“Complete”), a wholly-owned subsidiary of BGI-Shenzhen, a leading international genomics organization

Complete Genomics and Illumina Settle Patent Litigation
Parties agree to dismiss all claims and counterclaims in two lawsuits brought by Illumina. No payments or license grants are being made by either party.
MOUNTAIN VIEW, Calif. – 18 July 2013 – Complete Genomics, Inc. (formerly NASDAQ: GNOM) (“Complete”), a wholly-owned subsidiary of BGI-Shenzhen

BGI-Shenzhen Completes Acquisition of Complete Genomics
Combined Company to Focus on High Volume, Accurate Human Genomic Sequencing and Accelerating the Spread of Genomic Medicine
SHENZHEN, China and MOUNTAIN VIEW, Calif. – 18 March 2013 – BGI-Shenzhen (“BGI”), a leading international genomics organization based in Shenzhen, China, today announced that through its wholly-owned